Characterization of a cis-acting sequence in the pol region required to transfer human foamy virus vectors

Journal of Virology

Volumn 72, Issue 8, 1998, Pages 6307-6314

  Heinkelein, Martin ^a   Schmidt, Michael ^a,b   Fischer, Nicole ^a,c   Moebes, Astrid ^a   Lindemann, Dirk ^a   Enssle, Jörg ^a   Rethwilm, Axel ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; VIRUS VECTOR;

ARTICLE; GENE TRANSFER; NUCLEIC ACID ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPUMA VIRUS; VIRUS GENOME; VIRUS REPLICATION;

EID: 0031902657     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.8.6307-6314.1998     Document Type: Article

References (54)

1. Ausubel, F. M., R. Brent, R. E. Kingston, D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1987. Current protocols in molecular biology. John Wiley & Sons, New York, N.Y.
2. Baum, C., K. Itoh, J. Meyer, C. Laker, Y. Ito, and W. Ostertag. 1997. The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF. J. Virol. 71:6323-6331.
3. Baunach, G., B. Maurer, H. Hahn, M. Kranz, and A. Rethwilm. 1993. Functional analysis of human foamy virus accessory reading frames. J. Virol. 67:5411-5418.
4. Berkowitz, R., J. Fischer, and S. P. Goff. 1996. RNA packaging. Curr. Top. Microbiol. Immunol. 214:177-218.
5. Bieniasz, P. D., O. Erlwein, A. Aguzzi, A. Rethwilm, and M. O. McClure. 1997. Gene transfer using replication-defective human foamy virus vectors. Virology 235:65-72.
6. Bodem, J., M. Löchelt, I. Winkler, R. P. Flower, H. Delius, and R. M. Flügel. 1996. Characterization of the spliced pol transcript of feline foamy virus: the splice acceptor site of the pol transcript is located in gag of foamy viruses. J. Virol. 70:9024-9027.
7. Bray, M., S. Prasad, J. W. Dubay, E. Hunter, K.-T. Jeang, D. Rekosh, and M.-L. Hammarskjold. 1994. A small element from Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication rev-independent. Proc. Natl. Acad. Sci. USA 91:1256-1260.
8. Charneau, P., M. Alizon, and F. Clavel. 1992. A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J. Virol. 66:2814-2820.
9. Charneau, P., and F. Clavel. 1991. A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. J. Virol. 65:2415-2421.
10. Cullen, B. R. 1991. Human immunodeficiency virus as a prototypic complex retrovirus. J. Virol. 65:1053-1056.
11. Cullen, B. R. 1994. RNA-sequence-mediated gene regulation in HIV-1. Infect. Agents Dis. 3:68-76.
12. DuBridge, R. B., P. Tang, H. C. Hsia, P.-M. Leong, J. H. Miller, and M. P. Calos. 1987. Analysis of mutation in human cells by using Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:379-387.
13. Enssle, J., N. Fischer, A. Moebes, B. Mauer, U. Smola, and A. Rethwilm. 1997. Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle. J. Virol. 71:7312-7317.
14. Enssle, J., I. Jordan, B. Mauer, and A. Rethwilm. 1996. Foamy virus reverse transcriptase is expressed independently from the gag protein. Proc. Natl. Acad. Sci. USA 93:4137-4141.
15. Erlwein, O., D. Cain, N. Fischer, A. Rethwilm, and M. O. McClure. 1997. Identification of sites that act together to direct dimerization of human foamy virus RNA in vitro. Virology 229:251-258.
16. Fischer, N., M. Heinkelein, D. Lindemann, J. Enssle, C. Baum, E. Werder, H. Zentgraf, J. G. Müller, and A. Rethwilm. 1998. Foamy virus particle formation. J. Virol. 72:1610-1615.
17. Hahn, H., G. Baunach, S. Bräutigam, A. Mergia, D. Neumann-Haefelin, M. D. Daniel, M. O. McClure, and A. Rethwilm. 1994. Reactivity of primate sera to foamy virus gag and bet proteins. J. Gen. Virol. 75:2635-2644.
18. Hirata, R. K., A. D. Miller, R. G. Andrews, and D. W. Russel. 1996. Transduction of hematopoietic cells by foamy virus vectors. Blood 88:3654-3661.
19. Huang, J., and T. J. Liang. 1993. A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products. Mol. Cell. Biol. 13:7476-7486.
20. Huang, Z.-M., and T. S. B. Yen. 1994. Hepatitis B virus RNA element that facilitates accumulation of surface gene transcripts in the cytoplasm. J. Virol. 68:3193-3199.
21. Jordan, I., J. Enssle, E. Güttler, B. Mauer, and A. Rethwilm. 1996. Expression of human foamy virus reverse transcriptase involves a spliced pol mRNA. Virology 224:314-319.
22. Kim, V. N., K. Mitrophanous, S. M. Kingsman, and A. J. Kingsman. 1998. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J. Virol. 72:811-816.
23. Kögel, D., M. Aboud, and R. M. Flügel. 1995. Molecular biological characterization of the human foamy virus reverse transcriptase and ribonuclease H domains. Virology 213:97-108.
24. Konvalinka, J., M. Löchelt, H. Zentgraf, R. M. Flügel, and H.-G. Kräusslich. 1995. Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein. J. Virol. 69:7264-7268.
25. Kupiec, J. J., J. Tobaly-Tapiero, M. Canivet, M. Santillana-Hayat, R. M. Flügel, J. Peries, and R. Emanoil-Ravier. 1988. Evidence for a gapped linear duplex DNA intermediate in the replicative cycle of human and simian spumaviruses. Nucleic Acids Res. 16:9557-9565.
26. Lindemann, D., M. Bock, M. Schweizer, and A. Rethwilm. 1997. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J. Virol. 71:4815-4820.
27. Lindemann, D., and A, Rethwilm. 1998. Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing. J. Virol. 72:4088-4094.
28. Linial, M. L., and A. D. Miller. 1990. Retroviral RNA packaging: sequence requirements and implications. Curr. Top. Microbiol. Immunol. 157:125-152.
29. Löchelt, M., and R. M. Flügel. 1996. The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein. J. Virol. 70:1033-1040.
30. Löchelt, M., R. M. Flügel, and M. Aboud. 1994. The human foamy virus internal promoter directs the expression of the functional Bel 1 transactivator and Bet protein early after infection. J. Virol. 68:638-645.
31. Löchelt, M., W. Muranyi, and R. M. Flügel. 1993. Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter. Proc. Natl. Acad. Sci. USA 90:7317-7321.
32. Maurer, B., H. Bannert, G. Darai, and R. M. Flügel. 1988. Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J. Virol. 62:1590-1597.
33. Miller, A. D. 1997. Development and applications of retroviral vectors, p. 437-473. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
34. Moebes, A., J. Enssle, P. D. Bieniasz, M. Heinkelein, D. Lindemann, M. Bock, M. O. McClure, and A. Rethwilm. 1997. Human foamy virus reverse transcription that occurs late in the viral replication cycle. J. Virol. 71:7305-7311.
35. Muranyi, W., and R. M. Flügel. 1991. Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures. J. Virol. 65:727-735.
36. Naldini, L., U. Blömer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
37. 60Co gamma rays. Int. J. Cancer 35:275-280.
38. Nassal, M., and H. Schaller. 1993. Hepatitis B virus replication. Trends Microbiol. 1:221-228.
39. Nestler, U., M. Heinkelein, M. Lücke, J. Meixensberger, W. Scheurlen, A. Kretschmer, and A. Rethwilm. 1997. Foamy virus vectors for suicide gene therapy. Gene Ther. 4:1270-1277.
40. Netzer, K. O., A. Schliephake, B. Maurer, R. Watanabe, A. Aguzzi, and A. Rethwilm. 1993. Identification of pol-related gene products of human foamy virus. Virology 192:335-338.
41. Ogert, R. A., L. H. Lee, and K. L. Beemon. 1996. Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm. J. Virol. 70:3834-3843.
42. Parolin, C., B. Taddeo, G. Palu, and J. Sodroski. 1996. Use of cis-and trans-acting regulatory sequences to improve expression of human immunodeficiency virus vectors in human lymphocytes. Virology 222:415-422.
43. Rethwilm, A. 1995. Regulation of foamy virus gene expression. Curr. Top. Microbiol. Immunol. 193:1-23.
44. Rethwilm, A. 1996. Unexpected replication pathways of foamy viruses. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13(Suppl. 1):S248-S253.
45. Russell, D. W., and A. D. Miller. 1996. Foamy virus vectors. J. Virol. 70: 217-222.
46. Schmidt, M., O. Herchenröder, J. Heeney, and A. Rethwilm. 1997. Long terminal repeat U3 length polymorphism of human foamy virus. Virology 230:167-178.
47. Schmidt, M., and A. Rethwilm. 1995. Replicating foamy virus-based vectors directing high level expression of foreign genes. Virology 210:167-178.
48. Soneoka, Y., P. M. Cannon, E. E. Ramsdale, J. C. Griffith, G. Romano, S. M. Kingsman, and A. J. Kingsman. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:628-633.
49. Tabernero, C., A. S. Zolotukhin, J. Bear, R. Schneider, G. Karsenty, and B. K. Felber. 1997. Identification of an RNA sequence within an intracisternal-A particle element able to replace Rev-mediated posttranscriptional regulation of human immunodeficiency virus type 1. J. Virol. 71:95-101.
50. Telenitzky, A., and S. P. Goff. 1997. Reverse transcriptase and the generation of retroviral DNA, p. 121-160. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
51. Tobaly-Tapiero, J., J. J. Kupiec, M. Santillana-Hayat, M. Canicet, J. Peries, and R. Emanoil-Ravier. 1991. Further characterization of the gapped DNA intermediates of human spumavirus: evidence for a dual initiation of plus-strand DNA synthesis. J. Gen. Virol. 72:605-608.
52. Weiss, R. A. 1996. Foamy viruses bubble on. Nature 380:201.
53. Yu, S. F., D. N. Baldwin, S. R. Gwynn, S. Yendapalli, and M. L. Linial. 1996. Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 271:1579-1582.
54. Zolotukhin, A. S., A. Valentin, G. N. Pavlakis, and B. K. Felber. 1994. Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J. Virol. 68:7944-7952.